JLE

Epileptic Disorders

MENU

Stereotactic amygdalohippocampectomy for temporal lobe epilepsy: promising results in 16 patients Volume 9, supplement 5, Supplement n°1, December 2007

Figure 1 Results in patient 13. A) MRI showing mesial temporal sclerosis left; B, C) FDG-PET showing left temporal hypometabolism; D, E, F, G) MRI 3 days following stereotactic amygdalohippocampectomy; H) MRI 6 months following stereotactic AHE.

Figure 2 Results in patient 5. A) MRI showing mesial temporal sclerosis left; B, C) FDG-PET showing left temporal hypometabolism; D, E, F, G) MRI 3 days following stereotactic amygdalohippocampectomy; H) MRI 25 months following stereotactic AHE.

Figure 3 Results in patient 16. A) MRI showing mesial temporal sclerosis left; B, C) FDG-PET showing left temporal hypometabolism; D, E, F, G) MRI 2 days following stereotactic amygdalohippocampectomy; H) MRI 3 months following stereotactic AHE.

Figure 4 Results in patient IK. A) MRI showing mesial temporal sclerosis left; B, C) FDG-PET showing left temporal hypometabolism; D, E, F, G) MRI 3 days following stereotactic amygdalohippocampectomy; H) MRI 9 months following stereotactic AHE.